Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Atossa Genetics Inc. (ATOS) had Consolidated Net Income/Loss of $-8.69M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.69M |
|
-- |
|
-- |
|
$9.25M |
|
$-9.25M |
|
$0.56M |
|
$-8.69M |
|
$-8.69M |
|
$-8.69M |
|
$-8.69M |
|
|
Consolidated Net Income/Loss |
$-8.69M |
$-8.69M |
|
$-9.25M |
|
$-9.25M |
|
129.17M |
|
129.17M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$55.68M |
|
-- |
|
$2.33M |
|
$58.01M |
|
$8.22M |
|
-- |
|
-- |
|
$8.22M |
|
$49.79M |
|
$49.79M |
|
$49.79M |
|
129.17M |
|
| Cash Flow Statement Financials | |
$-19.22M |
|
$-0.02M |
|
-- |
|
$71.19M |
|
$51.95M |
|
$-19.24M |
|
$2.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.46% |
|
-17.46% |
|
-14.98% |
|
-17.46% |
|
$0.39 |
|
$-0.15 |
|
$-0.15 |
|